Literature DB >> 7216135

Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.

G Pastore, P Dentico, G Angarano, E Lapedota, O Schiraldi.   

Abstract

Sera from 28 HBsAg chronic carriers were tested for the presence of HBeAg, anti-HBe and Dane particle-associated DNA-polymerase activity, in order to evaluate the relationship between the presence of these markers and the spread of HBV infection in their family contacts. A highly significant prevalence of HBV infection was observed in the relatives of HBsAg carriers who were positive for either HBeAg or DNA-polymerase activity or both. These observations support the inference of a striking correlation between the presence of these markers and the infectivity of HBsAg carriers. Therefore, serological determination of HBeAg and DNA-polymerase activity may be considered in the epidemiological control of HBV infection

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216135

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Mitra Ranjbar; Shahin Ansari; Seyed Moayed Alavian; Hamid Mohaghegh Shalmani; Leila Hekmat; Mohammad Reza Zali
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

2.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01

3.  Hepatitis B antigen and antibody in the blood of prostitutes visiting an outpatient venereology department in Rotterdam.

Authors:  D de Hoop; W J Anker; R van Strik; N Masurel; E Stolz
Journal:  Br J Vener Dis       Date:  1984-10

4.  Risk of hepatitis B in a ward for mentally retarded HBsAg carriers.

Authors:  J Eskola; J Keski-Oja; M Wilska; S Autio
Journal:  Infection       Date:  1986 Jul-Aug       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.